SAILIFENSESai Life Sciences LimitedMediumNeutral
Announced Tue, 17 Jun · 10:53 IST

Sai Life Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot

Board & Shareholder Meetings View source PDF

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sai Life Sciences Limited announced the results of its postal ballot (e-voting held from May 18 to June 16, 2025) for six resolutions, all of which were passed by shareholders. Four resolutions dealt with ratification of the ESOP Scheme 2008 and Management ESOP Scheme 2018, including extending their benefits to employees of subsidiary and group companies — these passed with 84.55% votes in favor. Two resolutions related to director appointments: Dr. Dinesh V Patel as Independent Director passed with 99.69% support, and Mr. Sivaramakrishnan Chittor as Whole-Time Director passed with 96.35% support. Promoters voted 100% in favor of all resolutions. Public institutional investors showed notable dissent (~15.45%) on the ESOP-related resolutions, while public non-institutional shareholders overwhelmingly supported all resolutions (~99.98%).

Likely market impact

All six resolutions were approved with the required majority, providing continuity for the company's stock option plans and completing the board appointments. The 15%+ dissent from public institutional investors on ESOP ratifications is worth noting but did not block the resolutions; minimal impact on share price is expected as the outcomes were largely anticipated.